KRMD KORU Medical Systems, Inc.
Healthcare$4.20+2.44%ClosedMarket Cap: $192.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
11.23
P/S
4.35
EV/EBITDA
-101.53
DCF Value
$-10.98
FCF Yield
0.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.5%
Operating Margin
-6.0%
Net Margin
-5.3%
ROE
-13.6%
ROA
-8.0%
ROIC
-12.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $11.8M | 59.8% | $-864.9K | $-807.1K | $— | — |
| Q4 null | $10.9M | 62.6% | $-547.1K | $-486.9K | $— | — |
| FY null | $41.1M | 62.3% | $-3.0M | $-2.6M | $— | — |
| Q3 null | $10.4M | 60.2% | $-867.7K | $-778.0K | $— | — |
| Q2 null | $10.2M | 63.5% | $-312.7K | $-206.9K | $— | — |
| Q1 null | $9.6M | 62.8% | $-1.2M | $-1.2M | $— | — |
| Q4 null | $8.8M | 62.9% | $-1.6M | $-1.6M | $— | — |
| FY null | $33.6M | 63.4% | $-6.4M | $-6.1M | $— | — |
| Q3 null | $8.2M | 63.4% | $-1.7M | $-1.6M | $— | — |
| Q2 null | $8.4M | 65.0% | $-1.2M | $-988.7K | $— | — |
| Q1 null | $8.2M | 62.3% | $-2.0M | $-1.9M | $— | — |
| Q4 2023 | $7.2M | 60.3% | $-2.2M | $-7.5M | $-0.16 | — |